ERP Proposal SPDS Set 2

ASHWAGANDHA

Anton Bzhelyansky USP MURALI BALASURAMANIAN NATURAL REMEDIES Premal Bhatt USP Nour Eddine ES‐SAFI

Mohammed V University in Rabat

Prashant Ingle Tom Phillips

Herbalife

State of Maryland

Catherine Rimmer

NIST

Casey Sayre Aniko Solyom Darryl Sullivan

Roseman University of Health Sciences

GAAS Analytical

Covance

Kurt Young

GNC/Nutra Manufacturing

Yanjun Zhang

Herbalife 

Ashwagandha ‐ By Broad Perspectives ACADEMIA GOVERNMENT INDUSTRY NGO

17%

16%

Ashwagandha ‐ By Region USA INDIA MOROCCO

17%

8%

50%

9%

Ashwagandha ‐ By Specific Perspectives CRO MANUFACTURER REFERENCE MATERIALS REGULATOR RESEARCH

83%

17%

17%

8%

33%

25%